Overview

  • Product nameAnti-GPD1L antibody
    See all GPD1L primary antibodies
  • Description
    Rabbit polyclonal to GPD1L
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
  • Immunogen

    Synthetic peptide conjugated to KLH, corresponding to N terminal amino acids 47-77 of Human GPD1L (NP_055956.1)

  • Positive control
    • MCF-7 cell line lysate Mouse heart tissue lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab107509 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 38 kDa.

Target

  • FunctionPlay a role in regulating cardiac sodium current; decreased enzymatic activity with resulting increased levels of glycerol 3-phosphate activating the DPD1L-dependent SCN5A phosphorylation pathway, may ultimately lead to decreased sodium current; cardiac sodium current may also be reduced due to alterations of NAD(H) balance induced by DPD1L.
  • Tissue specificityMost highly expressed in heart tissue, with lower levels in the skeletal muscle, kidney, lung and other organs.
  • Involvement in diseaseDefects in GPD1L are the cause of Brugada syndrome type 2 (BRS2) [MIM:611777]. BRS2 is an autosomal dominant tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs (called ventricular fibrillation), the individual will faint and may die in a few minutes if the heart is not reset.
    Defects in GPD1L are a cause of sudden infant death syndrome (SIDS) [MIM:272120]. SIDS is the sudden death of an infant younger than 1 year that remains unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of clinical history. Pathophysiologic mechanisms for SIDS may include respiratory dysfunction, cardiac dysrhythmias, cardiorespiratory instability, and inborn errors of metabolism, but definitive pathogenic mechanisms precipitating an infant sudden death remain elusive.
  • Sequence similaritiesBelongs to the NAD-dependent glycerol-3-phosphate dehydrogenase family.
  • Cellular localizationCytoplasm. Localized to the region of the plasma membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • 2210409H23Rik antibody
    • D9Ertd660e antibody
    • Glycerol 3 phosphate dehydrogenase 1 like antibody
    • Glycerol 3 phosphate dehydrogenase 1 like protein antibody
    • Glycerol-3-phosphate dehydrogenase 1-like protein antibody
    • GPD 1L antibody
    • GPD1-L antibody
    • gpd1l antibody
    • GPD1L_HUMAN antibody
    • KIAA0089 antibody
    • RGD1560123 antibody
    see all

Anti-GPD1L antibody images

  • Anti-GPD1L antibody (ab107509) at 1/100 dilution + MCF-7 cell line lysate at 35 µg

    Predicted band size : 38 kDa
  • Anti-GPD1L antibody (ab107509) at 1/100 dilution + Mouse heart tissue lysate at 35 µg

    Predicted band size : 38 kDa

References for Anti-GPD1L antibody (ab107509)

ab107509 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab107509.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"